In Search of Clinical Biomarkers of Response to Checkpoint Inhibitor Therapy in Renal Cell Carcinoma

被引：1
|
作者：
Fan, Alice C. [2 ]
Leppert, John T. [1 ]
机构：
[1] Stanford Univ, Dept Urol, Sch Med, 300 Pasteur Dr,Grant S-287, Stanford, CA 94305 USA
[2] Stanford Univ, Div Oncol, Dept Med, Sch Med, Stanford, CA 94305 USA
来源：
JAMA NETWORK OPEN | 2021年 / 4卷 / 01期
关键词：
D O I：
10.1001/jamanetworkopen.2020.35120
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Sequencing checkpoint inhibitor therapy in renal cell carcinoma
    Beckermann, Kathryn E.
    Rini, Brian
    LANCET, 2023, 402 (10397): : 160 - 161
  • [2] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
    Brown, Landon C.
    Zhu, Jason
    Desai, Kunal
    Kinsey, Emily
    Kao, Chester
    Lee, Yong Hee
    Pabla, Sarabjot
    Labriola, Matthew K.
    Tran, Jennifer
    Dragnev, Konstantin H.
    Tafe, Laura J.
    Dayyani, Farshid
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Glenn, Sean T.
    Nesline, Mary K.
    George, Saby
    Zibelman, Matthew
    Morrison, Carl
    Ornstein, Moshe C.
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [3] Biomarkers for evaluating the clinical response to immune checkpoint inhibitors in renal cell carcinoma (Review)
    Gonzalez-Garza, Raquel
    Gutierrez-Gonzalez, Adrian
    Salinas-Carmona, Mario Cesar
    Mejia-Torres, Manuel
    ONCOLOGY REPORTS, 2024, 52 (06)
  • [4] Complete and Prolonged Response of Renal Cell Carcinoma With Rhabdoid Features to Checkpoint Inhibitor Therapy
    Wynja, Emily
    Solomon, Benjamin
    Bleeker, Jonathan
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (07) : 340 - 342
  • [5] The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
    Knepper, Todd C.
    Montesion, Meagan
    Russell, Jeffery S.
    Sokol, Ethan S.
    Frampton, Garrett M.
    Miller, Vincent A.
    Albacker, Lee A.
    McLeod, Howard L.
    Eroglu, Zeynep
    Khushalani, Nikhil, I
    Sondak, Vernon K.
    Messina, Jane L.
    Schell, Michael J.
    DeCaprio, James A.
    Tsai, Kenneth Y.
    Brohl, Andrew S.
    CLINICAL CANCER RESEARCH, 2019, 25 (19) : 5961 - 5971
  • [6] Determinants of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor therapy response in renal cell carcinoma
    Gu, L.
    Liang, Q.
    Zhang, X.
    Wang, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1507 - S1507
  • [7] Clinical biomarkers of response in advanced renal cell carcinoma
    Ravaud, A.
    Schmidinger, M.
    ANNALS OF ONCOLOGY, 2013, 24 (12) : 2935 - 2942
  • [8] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean T.
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [9] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [10] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345